<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Besides cerebrovascular disease, medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> (MTA), a neuroimaging finding suggestive of degenerative pathology, has been shown in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is unknown to what extent MTA contributes to the pattern of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> observed in VaD </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, our purpose was to investigate the relative contribution of cerebrovascular disease and MTA to <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in patients fulfilling diagnostic criteria for VaD </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We examined 590 patients (374 men; mean age, 73 years; standard deviation, 8) with probable VaD according to the National Institute of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">Neurological Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo>-Association Internationale pour la Recherche et l'Enseignement en Neurosciences criteria at inclusion into a multicenter clinical trial </plain></SENT>
<SENT sid="4" pm="."><plain>Cerebrovascular disease and the degree of MTA were evaluated by using MRI </plain></SENT>
<SENT sid="5" pm="."><plain>Cognitive testing included the Mini-Mental State Examination, and the vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> assessment scale </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: On the basis of the operational definitions for the neuroimaging part of the National Institute of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">Neurological Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo>-Association Internationale pour la Recherche et l'Enseignement en Neurosciences criteria, 485 (82.2%) patients had small vessel VaD and 153 (25.9%) had large vessel VaD </plain></SENT>
<SENT sid="7" pm="."><plain>More than half (59.8%) of the patients had considerable MTA </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple linear regression analyses revealed that after correction for sex, age, education, and duration of <z:hpo ids='HP_0000726'>dementia</z:hpo>, neuropsychological tests showed that patients with higher grades of MTA or large vessel VaD had significantly worse general cognitive and executive functioning, whereas associations with small vessel disease were restricted to worse executive functioning </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Both MTA and large vessel disease contribute to global <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in VaD </plain></SENT>
<SENT sid="10" pm="."><plain>Small vessel disease contributes to executive dysfunction </plain></SENT>
</text></document>